As of 2024-12-14, the Fair Value of Maat Pharma SA (MAAT.PA) is -8.69 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.90 EUR, the upside of Maat Pharma SA is -209.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -5.84 | -5.30 | -9.02 | -13.71 | -19.72 | -10.72 |
| YoY growth | -30.59% | 9.29% | -70.14% | -52.05% | -43.78% | -37.45% |
| Market Cap (mil) | 109.75 |
| P/E | |
| Forward P/E |
| EPS | -1.74 |
| Avg earnings growth rate | -37.45% |
| TTM earnings | -24.14 |